Owners and operators of Shanxi Osteorad Biomaterial Co. and Sichuan Hengpu Technology Co. are accused of receiving more than 4,000 cadavers via illegal means, allowing the former to turn over nearly $53 million in revenue from 2015-2023.
The alleged corpse trafficking spanned at least seven provinces and nearly a dozen localities, where dead bodies were either transferred, dissected, stored or turned into material devices for bone-grafting procedures, according to a leaked May indictment by the Taiyuan People’s Procuratorate in Shanxi province. 山西奥斯特拉德生物材料有限公司和四川恒普科技有限公司的所有者和经营者被指控通过非法手段接收了超过 4,000 具尸体，这使得前者在 2015 年至 2023 年期间获得了近 5,300 万美元的收入。
据山西省太原市人民检察院 5 月份泄露的起诉书显示，涉嫌贩卖尸体的行为至少涉及七个省和近十几个地方，尸体被转移、解剖、储存或制成骨移植手术的材料装置。
Thousands of Corpses Traded in Medical Industry Scandal 医疗行业丑闻 数千具尸体被交易
https://www.newsweek.com/china-thousands-corpses-smuggled-bone-graft-medical-health-scandal-1936276
国药集团子公司否认与涉嫌非法购买尸体的公司有联系 Sinopharm unit denies link to firm suspected of illegally purchasing cadavers
